June 28, 2019 – Hanwha Q CELLS understands that certain statements were made regarding Jinko and REC's filing of an Inter Partes Review (IPR) petition challenging Hanwha Q CELLS' patent in response to its patent infringement complaints filed with the U.S. International Trade Commission (ITC) and the U.S. District Court for the District of Delaware in March. The filing of an IPR petition is a fairly standard reaction in U.S. litigation to a claim of infringement, and Hanwha Q CELLS believes the petition is without merit.
Hanwha Q CELLS will defend the validity of its patent rights against Jinko and REC's claims of invalidity in the IPR as well as in the ITC. However, Hanwha Q CELLS does not believe it is appropriate to litigate this dispute in the media and therefore does not intend to
